| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |